Nishiguchi Koji M, Sandberg Michael A, Kooijman Aart C, Martemyanov Kirill A, Pott Jan W R, Hagstrom Stephanie A, Arshavsky Vadim Y, Berson Eliot L, Dryja Thaddeus P
Ocular Molecular Genetics Institute, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 02114, USA.
Nature. 2004 Jan 1;427(6969):75-8. doi: 10.1038/nature02170.
The RGS proteins are GTPase activating proteins that accelerate the deactivation of G proteins in a variety of signalling pathways in eukaryotes. RGS9 deactivates the G proteins (transducins) in the rod and cone phototransduction cascades. It is anchored to photoreceptor membranes by the transmembrane protein R9AP (RGS9 anchor protein), which enhances RGS9 activity up to 70-fold. If RGS9 is absent or unable to interact with R9AP, there is a substantial delay in the recovery from light responses in mice. We identified five unrelated patients with recessive mutations in the genes encoding either RGS9 or R9AP who reported difficulty adapting to sudden changes in luminance levels mediated by cones. Standard visual acuity was normal to moderately subnormal, but the ability to see moving objects, especially with low-contrast, was severely reduced despite full visual fields; we have termed this condition bradyopsia. To our knowledge, these patients represent the first identified humans with a phenotype associated with reduced RGS activity in any organ.
RGS蛋白是GTP酶激活蛋白,可加速真核生物各种信号通路中G蛋白的失活。RGS9使视杆和视锥光转导级联反应中的G蛋白(转导蛋白)失活。它通过跨膜蛋白R9AP(RGS9锚定蛋白)锚定在光感受器膜上,R9AP可将RGS9的活性提高多达70倍。如果RGS9缺失或无法与R9AP相互作用,小鼠从光反应中恢复的时间会大幅延迟。我们鉴定出五名无关患者,他们在编码RGS9或R9AP的基因中存在隐性突变,这些患者报告称难以适应视锥介导的亮度水平突然变化。标准视力正常至中度低于正常水平,但尽管视野完整,他们看移动物体的能力,尤其是低对比度物体的能力严重下降;我们将这种情况称为视力迟缓。据我们所知,这些患者是首次被鉴定出的与任何器官中RGS活性降低相关表型的人类。